Creyos Partners with Redox to Eliminate Barriers to Cognitive Health Data in EHRs

Partnership redefines how health systems bring cognitive screening into routine care at scale

TORONTO, May 13, 2025 /PRNewswire/ -- Creyos, the leading online platform for objective cognitive and behavioral health assessments, today announced its partnership with Redox, a leading provider of healthcare data interoperability solutions. This strategic collaboration enables large health systems and integrated delivery networks to seamlessly embed Creyos' cognitive testing into their electronic health records (EHRs), eliminating one of the biggest barriers to scaling proactive brain health care.

This partnership comes at a time when cognitive and behavioral health assessments are becoming essential to high-quality, preventive care. Over 55 million people worldwide are currently living with dementia, and that number is projected to reach 139 million by 2050. Early and accurate screening is critical for enabling timely intervention, personalized care planning, and improved outcomes. As health systems shift toward value-based care, Creyos is helping providers make cognitive health a core part of routine care. Its tools are clinically proven and easy to implement.

Most technology fails to gain traction in large health systems due to poor alignment with clinical workflows. Creyos overcomes this by leveraging Redox's expansive EHR network to deliver seamless data integration and platform access. Its scientifically validated dementia screening and assessments are now available at the point of care, right when providers need them.

"We're at a turning point in how health systems approach cognitive health," said Marc Lipton, CEO of Creyos. "To deliver on the promise of value-based care, we need tools that don't just work clinically but also work operationally. This partnership with Redox eliminates the workflow and integration barriers that have slowed adoption for years. It puts Creyos assessments exactly where they need to be, within the systems clinicians already use."

Redox's platform supports interoperability across more than 90 EHR systems including, Cerner, eClinicalWorks, and Allscripts, among many others. Health systems deploying Creyos through this partnership can automatically deliver cognitive assessments and patient results to their EHRs without complex, time-consuming IT work.

This ensures:

• Timely Decision-Making: Providers receive screener and assessment data directly in their existing systems, allowing for faster clinical decision making, interventions, and coordinated care planning.
  
  
• Improved Clinical Workflow Efficiency: Automating the integration of cognitive test results reduces administrative burdens, giving providers more time to focus on patient care.
  
  
• Scalability for Large Health Systems: Whether supporting one location or a national network of clinics, the Creyos-Redox integration is highly scalable and adaptable to the unique needs of any enterprise system.
  
  
• Early Detection and Proactive Care: Cognitive health is a critical component of preventive care, especially in aging populations and for at-risk patient groups. By integrating Creyos' cognitive and behavioral assessments directly into EHRs, providers can monitor cognitive decline over time, ensuring they catch early warning signs of conditions such as dementia or mild cognitive impairment (MCI) before they worsen.

"Creyos is bringing cognitive health into everyday clinical workflows, and we're proud to power that shift," said Trip Hofer, CEO of Redox. "When results from tools like this are embedded directly into EHR systems, providers can act sooner, and patients benefit from more timely, connected care. This is exactly the kind of integration we believe healthcare needs more of."

Creyos EHR integration through Redox is now available for all Creyos customers. Health systems interested in getting Creyos for their practice can learn more by visiting www.creyos.com.

About Creyos
Creyos, formerly known as Cambridge Brain Sciences, is a pioneering healthcare technology company dedicated to transforming how healthcare providers assess and manage patient brain health. Supporting clinicians and health systems worldwide, the Creyos platform includes objective online tasks, digital behavioral health screeners, and condition-specific assessments that deliver actionable insights, promote early intervention, and enable evidence-based clinical decisions for various cognitive and behavioral health conditions, including dementia, ADHD, depression, anxiety, and others. Backed by 30 years of research and a normative database of over 85,000 participants, the FDA-registered Creyos platform has been published in over 400 peer reviewed studies and is recognized as a scientifically-validated solution for measuring and monitoring patient brain health. For more information about Creyos visit www.creyos.com.

About Redox
Redox is your highway to better healthcare. We help providers, payers, digital health vendors/independent service providers, EHRs, and Life Sciences companies power better care with seamless data interoperability. Our secure platform's read/write capabilities translate, normalize, and enrich complex healthcare data in real time. With more than 9,600 live connections, organizations across North America use Redox technology to achieve faster speed to value across a wide range of systems, applications, and workflows. For more information, visit www.redoxengine.com or follow us on LinkedIn and X.

Media Contact:
Erin Smith
Chief Marketing and Engagement Officer, Creyos
(647)-628-6748
[email protected]

SOURCE Creyos